-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
- Centessa Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$43.8M, a 76.1% decline year-over-year.
- Centessa Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$157M, a 8.86% increase year-over-year.
- Centessa Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2023 was -$151M, a 30.1% increase from 2022.
- Centessa Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2022 was -$216M, a 43.3% increase from 2021.
- Centessa Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2021 was -$381M, a 3474% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)